Abstract
Impaired linear growth has been shown to occur in individuals treated during childhood with single-dose and fractionated total body irradiation (TBI) before stem cell transplantation. Our objective was to describe the final heights attained and patient/treatment factors correlating with final height in a cohort of childhood cancer survivors treated with hyperfractionated TBI (total dose 1375 or 1500 cGy). Thirty individuals (18 men) were included in the study. The mean final height standard deviation score (s.d.s.) was −1.9±0.2, significantly lower than height s.d.s. at TBI (−0.2±0.2, P<0.001). Final height s.d.s. was significantly correlated with age at diagnosis, age at TBI and target height (P=0.04, P<0.001, P<0.001, respectively). Treatment with growth hormone (GH) (n=7) maintained mean height s.d.s. at −2.0 from the onset of GH therapy until attainment of final height. The mean final sitting height s.d.s. was −2.2±0.2 (n=16), significantly shorter than mean final standing height s.d.s. (P<0.01). In conclusion, treatment with hyperfractionated TBI is associated with a reduction in standing height and an even greater reduction in sitting height. Final height after hyperfractionated TBI was similar to that reported after fractionated TBI.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Thomas ED . History of haemopoietic cell transplantation. Br J Haematol 1999; 105: 330–339.
Ries LAG, Harkins D, Krapcho M, Mariotto A, Miller BA, Feuer EJ et al. (eds). SEER Cancer Statistics Review, 1975–2003. National Cancer Institute: Bethesda, 2006.
Sklar C, Boulad F, Small T, Kernan N . Endocrine complications of pediatric stem cell transplantation. Front Biosci 2001; 6: G17–G22.
Huma Z, Boulad F, Black P, Heller G, Sklar C . Growth in children after bone marrow transplantation for acute leukemia. Blood 1995; 86: 819–824.
Brauner R, Fontoura M, Zucker JM, Devergie A, Souberbielle JC, Prevot-Saucet C et al. Growth and growth hormone secretion after bone marrow transplantation. Arch Dis Child 1993; 68: 458–463.
Shalet SM, Brennan BM . Growth and growth hormone status after a bone marrow transplant. Horm Res 2002; 58: 86–90.
Hovi L, Saarinen-Pihkala UM, Vettenranta K, Lipsanen M, Tapanainen P . Growth in children with poor-risk neuroblastoma after regimens with or without total body irradiation in preparation for autologous bone marrow transplantation. Bone Marrow Transplant 1999; 24: 1131–1136.
Thomas BC, Stanhope R, Plowman PN, Leiper AD . Growth following single fraction and fractionated total body irradiation for bone marrow transplantation. Eur J Pediatr 1993; 152: 888–892.
Cohen A, Rovelli A, Bakker B, Uderzo C, van Lint MT, Esperou H et al. Final height of patients who underwent bone marrow transplantation for hematological disorders during childhood: a study by the Working Party for Late Effects-EBMT. Blood 1999; 93: 4109–4115.
Yahalom J, Fuks ZY . Strategies for the use of total body irradiation as systemic therapy in leukemia and lymphoma. In: Armitage JO, Antman KH (eds). High Dose Cancer Therapy. Williams and Wilkins: Baltimore, 1992, p 61.
Greulich W, Pyle S . Radiographic Atlas of Skeletal Development of the Hand and Wrist, 2nd edn. University Press: Stanford, 1959.
Brochstein JA, Kernan NA, Groshen S, Cirrincione C, Shank B, David E et al. Allogeneic bone marrow transplantation after hyperfractionated total body irradiation and cyclophosphamide in children with acute leukemia. N Engl J Med 1987; 317: 1618.
Hamill PV . Body weight, stature, and sitting height. US Vital and Health Statistics, Series 11, No. 126; Publication No. HSM 73–1606. US Government Printing Office: Washington DC, 1973.
Hamill PV . Selected body measurements of children 6–11 years. US Vital and Health Statistics, Series 11, No. 123; Publication No. HSM 73–160. US Government Printing Office: Washington DC, 1973.
Kuczmarski RJ, Ogden CL, Guo SS, Grummer-Strawn LM, Flegal KM, Mei Z et al. 2000 CDC Growth Charts for the United States: methods and development. Vital Health Stat 11 2002; 246: 1–190.
Tanner JM . Growth at Adolescence. Blackwell: Oxford, 1978, pp 28–39.
Bayley N, Pinneau SR . Tables for predicting adult height from skeletal age: revised for use with the Greulich-Pyle hand standards. J Pediatr 1952; 40: 423–441.
Tanner JM, Davies PS . Clinical longitudinal standards for height and height velocity for North American children. J Pediatr 1985; 107: 317–329.
Baker HW, Best JB, Burger HG . Arginine-infusion test for growth-hormone secretion. Lancet 1970; 2: 1193.
Gil-Ad I, Topper E, Laron Z . Oral clonidine as a growth hormone stimulation test. Lancet 1979; 2: 278–279.
Shulman HM, Sullivan KM, Weiden PL, McDonald GB, Stiker GE, Hachman R et al. Chronic graft versus host syndrome in man: A clinicopathologic study of 20 Seattle patients. Am J Med 1980; 69: 204–217.
Bakker B, Massa GG, Oostdijk W, Van Weel-Sipman MH, Vossen JM, Wit JM . Pubertal development and growth after total-body irradiation and bone marrow transplantation for haematological malignancies. Eur J Pediatr 2000; 159: 31–37.
Frisk P, Arvidson J, Gustafsson J, Lonnerholm G . Pubertal development and final height after autologous bone marrow transplantation for acute lymphoblastic leukemia. Bone Marrow Transplant 2004; 33: 205–210.
Clement-De Boers A, Oostdijk W, Van Weel-Sipman MH, Van den Broeck J, Wit JM, Vossen JM . Final height and hormonal function after bone marrow transplantation in children. J Pediatr 1996; 129: 544–550.
Couto-Silva AC, Trivin C, Esperou H, Michon J, Baruchel A, Lemaire P et al. Final height and gonad function after total body irradiation during childhood. Bone Marrow Transplant 2006; 38: 427–432.
Bakker B, Oostdijk W, Geskus RB, Stokvis-Brantsma WH, Vossen JM, Wit JM . Patterns of growth and body proportions after total body irradiation and hematopoietic stem cell transplantation during childhood. Pediatr Res 2006; 59: 259–264.
Holm K, Nysom K, Rasmussen MH, Hertz H, Jacobsen N, Skakkebaek NE et al. Growth, growth hormone and final height after BMT. Possible recovery of irradiation-induced growth hormone insufficiency. Bone Marrow Transplant 1996; 18: 1131–1136.
Sanders JE, Guthrie KA, Hoffmeister PA, Woolfrey AE, Carpenter PA, Appelbaum FR . Final adult height of patients who received hematopoietic cell transplantation in childhood. Blood 2005; 105: 1348–1354.
Shalitin S, Philip M, Stein J, Goshen Y, Carmi D, Yaniv I . Endocrine dysfunction and parameters of the metabolic syndrome after bone marrow transplantation during childhood and adolescence. Bone Marrow Transplant 2006; 37: 1109–1117.
Brauner R, Adan L, Souberbielle JC, Esperou H, Michon J, Devergie A et al. Contribution of growth hormone deficiency to the growth failure that follows bone marrow transplantation. J Pediatr 1997; 130: 785–792.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chemaitilly, W., Boulad, F., Heller, G. et al. Final height in pediatric patients after hyperfractionated total body irradiation and stem cell transplantation. Bone Marrow Transplant 40, 29–35 (2007). https://doi.org/10.1038/sj.bmt.1705694
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1705694
Keywords
This article is cited by
-
A systematic approach to the endocrine care of survivors of pediatric hematopoietic stem cell transplantation
Cancer and Metastasis Reviews (2020)
-
GH deficiency in cancer survivors in the transition age: diagnosis and therapy
Pituitary (2020)
-
Growth hormone treatment impact on growth rate and final height of patients who received HSCT with TBI or/and cranial irradiation in childhood: a report from the French Leukaemia Long-Term Follow-Up Study (LEA)
Bone Marrow Transplantation (2012)